214 related articles for article (PubMed ID: 18068196)
1. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
Yin H; Chao L; Chao J
Life Sci; 2008 Jan; 82(3-4):156-65. PubMed ID: 18068196
[TBL] [Abstract][Full Text] [Related]
2. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
3. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation.
Chao J; Yin H; Gao L; Hagiwara M; Shen B; Yang ZR; Chao L
Hypertension; 2008 Oct; 52(4):715-20. PubMed ID: 18768400
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.
Yao YY; Yin H; Shen B; Chao L; Chao J
Regul Pept; 2007 Apr; 140(1-2):12-20. PubMed ID: 17196272
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
Yin H; Chao L; Chao J
J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141
[TBL] [Abstract][Full Text] [Related]
7. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.
Chao J; Yin H; Yao YY; Shen B; Smith RS; Chao L
Hum Gene Ther; 2006 Dec; 17(12):1201-13. PubMed ID: 17081080
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
Agata J; Chao L; Chao J
Hypertension; 2002 Nov; 40(5):653-9. PubMed ID: 12411458
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Imamura H; Iwasaka T
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2473-9. PubMed ID: 18390819
[TBL] [Abstract][Full Text] [Related]
10. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
Yao YY; Yin H; Shen B; Chao L; Chao J
J Card Fail; 2007 Sep; 13(7):588-96. PubMed ID: 17826650
[TBL] [Abstract][Full Text] [Related]
11. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
12. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
Abwainy A; Babiker F; Akhtar S; Benter IF
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H104-12. PubMed ID: 26519026
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation.
Chen LL; Zhu TB; Yin H; Huang J; Wang LS; Cao KJ; Yang ZJ
Mol Biol Rep; 2010 Oct; 37(7):3067-72. PubMed ID: 19908164
[TBL] [Abstract][Full Text] [Related]
14. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
[TBL] [Abstract][Full Text] [Related]
17. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
Smith RS; Agata J; Xia CF; Chao L; Chao J
Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy.
Manchini MT; Serra AJ; Feliciano Rdos S; Santana ET; Antônio EL; de Tarso Camillo de Carvalho P; Montemor J; Crajoinas RO; Girardi AC; Tucci PJ; Silva JA
PLoS One; 2014; 9(7):e101270. PubMed ID: 24991808
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion.
Yoshida H; Zhang JJ; Chao L; Chao J
Hypertension; 2000 Jan; 35(1 Pt 1):25-31. PubMed ID: 10642270
[TBL] [Abstract][Full Text] [Related]
20. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
